Versant Ventures VII GP, L.P.insider trades
In SEC Form 4 filings, Versant Ventures VII GP, L.P. is listed as 10% owner of Lycia Therapeutics, Inc. (LYCA). Versant Ventures VII GP, L.P. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| LYCALycia Therapeutics, Inc. | 10% owner | 4 | Oct 28 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-28
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| LYCALycia Therapeutics, Inc. | Oct 26 | Oct 28 | C | 5,631,425 | not reported | not reported | 5,631,425 | No | Form 4 |
| LYCALycia Therapeutics, Inc. | Oct 26 | Oct 28 | C | 1,393,882 | not reported | not reported | 1,393,882 | No | Form 4 |
| LYCALycia Therapeutics, Inc. | Oct 26 | Oct 28 | C · derivative | 25,390,410 | not reported | not reported | not reported | No | Form 4 |
| LYCALycia Therapeutics, Inc. | Oct 26 | Oct 28 | C · derivative | 6,284,597 | not reported | not reported | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.